X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS AJANTA PHARMA DR. DATSONS LABS/
AJANTA PHARMA
 
P/E (TTM) x -10.9 24.7 - View Chart
P/BV x 0.2 10.2 1.6% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 DR. DATSONS LABS   AJANTA PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
AJANTA PHARMA
Mar-16
DR. DATSONS LABS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,720 7.3%   
Low Rs311,103 2.8%   
Sales per share (Unadj.) Rs133.0194.6 68.3%  
Earnings per share (Unadj.) Rs0.245.2 0.3%  
Cash flow per share (Unadj.) Rs6.650.3 13.1%  
Dividends per share (Unadj.) Rs08.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs128.8132.0 97.5%  
Shares outstanding (eoy) m31.6688.77 35.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.67.3 8.1%   
Avg P/E ratio x516.131.2 1,653.5%  
P/CF ratio (eoy) x11.828.1 42.2%  
Price / Book Value ratio x0.610.7 5.7%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m2,477125,299 2.0%   
No. of employees `000NANA-   
Total wages/salary Rs m562,570 2.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21117,275 24.4%  
Other income Rs m79166 47.3%   
Total revenues Rs m4,28917,442 24.6%   
Gross profit Rs m5695,807 9.8%  
Depreciation Rs m204451 45.4%   
Interest Rs m43049 879.8%   
Profit before tax Rs m135,474 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,460 0.4%   
Profit after tax Rs m54,014 0.1%  
Gross profit margin %13.533.6 40.2%  
Effective tax rate %48.026.7 180.1%   
Net profit margin %0.123.2 0.5%  
BALANCE SHEET DATA
Current assets Rs m6,8527,639 89.7%   
Current liabilities Rs m6,7112,715 247.2%   
Net working cap to sales %3.328.5 11.7%  
Current ratio x1.02.8 36.3%  
Inventory Days Days16143 372.1%  
Debtors Days Days31879 404.8%  
Net fixed assets Rs m3,6736,914 53.1%   
Share capital Rs m317177 179.0%   
"Free" reserves Rs m3,76111,442 32.9%   
Net worth Rs m4,07811,721 34.8%   
Long term debt Rs m1,671149 1,123.6%   
Total assets Rs m12,63314,814 85.3%  
Interest coverage x1.0112.9 0.9%   
Debt to equity ratio x0.40 3,229.8%  
Sales to assets ratio x0.31.2 28.6%   
Return on assets %3.427.4 12.6%  
Return on equity %0.134.2 0.3%  
Return on capital %7.746.5 16.5%  
Exports to sales %22.955.1 41.5%   
Imports to sales %14.36.0 238.0%   
Exports (fob) Rs m9649,527 10.1%   
Imports (cif) Rs m6021,038 58.0%   
Fx inflow Rs m96410,422 9.2%   
Fx outflow Rs m6071,678 36.2%   
Net fx Rs m3578,744 4.1%   
CASH FLOW
From Operations Rs m1,3453,264 41.2%  
From Investments Rs m-2,256-2,093 107.8%  
From Financial Activity Rs m-1,200-1,186 101.2%  
Net Cashflow Rs m-2,111-15 14,261.5%  

Share Holding

Indian Promoters % 4.5 73.8 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.6 -  
FIIs % 1.4 7.6 17.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.0 553.5%  
Shareholders   20,807 20,968 99.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   DISHMAN PHARMA  CADILA HEALTHCARE  SUVEN LIFE  PANACEA BIOTECH  GLENMARK PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - NATCO PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS